Consistently, DS-treated MC38 cells up-regulated the levels of M1-associated costimulatory molecules, including CD86 and MHC-II, while markedly down-regulating CD206, a surface marker of M2 macrophages (Fig. 2K and Fig. S2G), indicating that DS-treated tumor cells polarize macrophages. This evidence concerns the gene CD86 and neoplasm.